Novo Nordisk

(13 search results)

Novo Nordisk plans bigger play in rare diseases segment in India
Novo Nordisk gets USFDA nod for weight loss drug Wegovy as once a day pill
How India is turning out to be global pharma’s battleground for anti-obesity drugs
Novo Nordisk says patent expiry will not dent Ozempic's India market potential
Novo Nordisk slashes price of anti-obesity drug Wegovy as Lilly's Mounjaro sets sales record in India
Pfizer acquires start-up Metsera for $10 billion; know the leaders behind the small biopharma company
Big Pharma’s $10-billion tug-of-war for Metsera: a 3-year-old start-up with no revenues, products
Novo Nordisk's blockbuster drug Ozempic's India launch is imminent, so are its generic versions
Novo Nordisk's obesity drug Wegovy cuts risk of heart attack by 57% vs Eli Lilly’s tirzepatide, shows real-world study  
Indian doctors give big thumbs up to Ozempic and Wegovy as Novo Nordisk battles court cases in U.S.